Fig. 7
From: Single protein encapsulated SN38 for tumor-targeting treatment
Photographic images of tumors of each group at the end of experiments. Bottom: left, control groups on Day 10 when mice were euthanized due to fast tumor growth; right, SPESN38-5 PO group on Day 10. TOP: left, Irinotecan group (6 mice) on Day 21; right, SPESN38-5 IV group (7 mice) on Day 21. SPESN38-5 significantly reduced the tumor size at the end of the experiment